# F1 001-project-scaffold-ci - Analyze (S34 main merge reconciliation)

**Date**: 2026-11-05. **Pass**: post-merge consistency re-analysis for S33 CI optimization (FR-015 to FR-019, SC-006 to SC-009, T016 to T018) and S32 migration-version guard (FR-020, SC-010, US6, T019). Main was merged into the #54 branch after #59 and #55 landed.

## Entry check (LIFTER Spec Kit gate, PO S29-PO-2)

- [x] spec.md has numbered FRs, measurable SCs and Given/When/Then scenarios for both scopes: FR-015 to FR-019 / SC-006 to SC-009 / User Story 5 cover CI efficiency; FR-020 / SC-010 / User Story 6 cover cross-branch migration-version detection.
- [x] Clarifications cite binding S33-PO-4 for CI scope and S32-PO-3 plus S32-R3 for the migration guard; both explicitly state: No open ambiguities.
- [x] plan.md covers both CI optimization and migration guard scopes.
- [x] tasks.md contains unique IDs: T016 to T018 for CI and T019 tagged FR-020/SC-010 for migration guard.
- [x] This analysis is dated after the post-merge spec/plan/tasks edits; findings below have 0 open CRITICAL/HIGH.

## ID collision resolution

The main-side CI requirements retain FR-015 to FR-019 and SC-006 to SC-009, with tasks T016 to T018 and User Story 5. The #54 migration-guard side was renumbered only: FR-015 to FR-020, SC-006 to SC-010, T016 to T019, User Story 5 to User Story 6. References in spec, plan, tasks and traceability were updated. No tests cited feature IDs.

## Findings

- Scope and traceability: CI event/concurrency/browser/storage requirements map to the existing #60 workflow changes and T016 to T018; migration guard FR-020/SC-010 maps to the opt-in script, existing unit tests, and T019.
- No workflow behavior was authored in this conflict resolution; workflow changes come from the already merged main branch. Main CI efficiency requirements remain intact.
- The migration guard remains opt-in detection-only; the in-tree checker and CI wiring remain unchanged. No migration file or product behavior is changed by conflict resolution.
- Clarifications cover both approved scopes; no unresolved product decision or ambiguity was found.
- **CRITICAL**: none. **HIGH**: none.

## Verdict

**PASS - 0 CRITICAL, 0 HIGH.**
